OCFMR-ED Archives

PDQNet Core Research Team

ocfmr-ed@SPEEDY.OUHSC.EDU
Options: Use Classic View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Topic: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Pamidronate associated with high incremental costs per adverse event avoided in patients with metastatic breast cancer
"Edward E. Rylander, M.D." <[log in to unmask]>
Sat, 4 Aug 2001 11:05:52 -0500
text/plain (8 kB) , text/html (47 kB) , image001.gif (47 kB) , image002.gif (47 kB)

ATOM RSS1 RSS2